About Asgard Therapeutics
Asgard Therapeutics is a company based in Lund (Sweden) founded in 2017 by Cristiana Pires, Filipe Pereira, and Fabio Fiuza Rosa.. Asgard Therapeutics has raised $39.75 million across 5 funding rounds from investors including European Union, Novo Holdings and Johnson & Johnson Innovation. The company has 7 employees as of December 31, 2022. Asgard Therapeutics offers products and services including AT-108. Asgard Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Lund, Sweden
- Employees 7 as on 31 Dec, 2022
- Founders Cristiana Pires, Filipe Pereira, Fabio Fiuza Rosa
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asgard Executive Group Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$39.75 M (USD)
in 5 rounds
-
Latest Funding Round
$32.81 M (USD), Series A
Mar 14, 2024
-
Investors
European Union
& 6 more
-
Employee Count
7
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Asgard Therapeutics
Asgard Therapeutics offers a comprehensive portfolio of products and services, including AT-108. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Off-the-shelf therapy for cancer immunotherapy via direct cell reprogramming.
Unlock access to complete
Unlock access to complete
Funding Insights of Asgard Therapeutics
Asgard Therapeutics has successfully raised a total of $39.75M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $32.81 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $32.8M
-
First Round
First Round
(01 Dec 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series A - Asgard Therapeutics | Valuation | Johnson & Johnson Innovation , RV Invest | |
| Jul, 2023 | Amount | Grant - Asgard Therapeutics | Valuation |
investors |
|
| Nov, 2021 | Amount | Seed - Asgard Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asgard Therapeutics
Asgard Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Novo Holdings and Johnson & Johnson Innovation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Healthcare investments are targeted by Boehringer Ingelheim Venture Fund.
|
Founded Year | Domain | Location | |
|
Investments in deep-tech, life sciences, and transformative tech are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asgard Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asgard Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asgard Therapeutics Comparisons
Competitors of Asgard Therapeutics
Asgard Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asgard Therapeutics
Frequently Asked Questions about Asgard Therapeutics
When was Asgard Therapeutics founded?
Asgard Therapeutics was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Asgard Therapeutics located?
Asgard Therapeutics is headquartered in Lund, Sweden.
Who is the current CEO of Asgard Therapeutics?
Cristiana Pires is the current CEO of Asgard Therapeutics. They have also founded this company.
Is Asgard Therapeutics a funded company?
Asgard Therapeutics is a funded company, having raised a total of $39.75M across 5 funding rounds to date. The company's 1st funding round was a Seed of $6.94M, raised on Dec 01, 2019.
How many employees does Asgard Therapeutics have?
As of Dec 31, 2022, the latest employee count at Asgard Therapeutics is 7.
What does Asgard Therapeutics do?
Asgard Therapeutics was established in 2017 in Lund, Sweden, within the biotechnology sector. Focus is placed on creating immunotherapeutic solutions for cancer through direct cell reprogramming. The TrojanDC approach is utilized, involving dendritic cell reprogramming to enhance anti-tumor immunity and suppress T-cell responses against cancers. Gene therapy-based methods are employed to render cancer cells immunogenic and activate the immune system. Operations center on advancing these technologies for therapeutic applications.
Who are the top competitors of Asgard Therapeutics?
Asgard Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Asgard Therapeutics offer?
Asgard Therapeutics offers AT-108.
Who are Asgard Therapeutics's investors?
Asgard Therapeutics has 7 investors. Key investors include European Union, Novo Holdings, Johnson & Johnson Innovation, Boehringer Ingelheim Venture Fund, and Industrifonden.